AI & ChatGPT searches , social queriess for BRODALUMAB

Search references for BRODALUMAB. Phrases containing BRODALUMAB

See searches and references containing BRODALUMAB!

AI searches containing BRODALUMAB

BRODALUMAB

  • Brodalumab

    • Monoclonal antibody

    Brodalumab, sold under the brand name Siliq in the US and Kyntheum in the EU, is a human monoclonal antibody designed for the treatment of inflammatory

    Brodalumab

    Brodalumab

  • Bausch Health

    • Canadian pharmaceutical company

    libido drug Addyi. In September 2015, Valeant licensed psoriasis drug Brodalumab from AstraZeneca for up to $445 million. In September 2015, the company

    Bausch Health

    Bausch_Health

  • Amgen

    • American multinational biopharmaceutical company

    company, in conjunction with AstraZeneca, reported positive results for brodalumab in a Phase III trial comparing the compound with ustekinumab and a placebo

    Amgen

    Amgen

    Amgen

  • AstraZeneca

    • Swedish-British pharmaceutical company

    Human papillomavirus types 16 and 18. In September, Valeant licensed Brodalumab from the company for up to US$445 million. On 6 November, it was reported

    AstraZeneca

    AstraZeneca

    AstraZeneca

  • Psoriasis

    • Autoimmune diseases of the skin

    psoriasis. There is also some evidence to support use of secukinumab, brodalumab, guselkumab, certolizumab, and ustekinumab. In general, anti-IL17, anti-IL12/23

    Psoriasis

    Psoriasis

    Psoriasis

  • Ixekizumab

    • Medication used to treat autoimmune diseases

    This mechanism is similar to that of another anti-psoriasis antibody, brodalumab, which binds to the interleukin-17 receptor. The antibody has affinity

    Ixekizumab

    Ixekizumab

  • Pacibekitug

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Pacibekitug

    Pacibekitug

  • Dupilumab

    • Drug used to treat allergic diseases

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Dupilumab

    Dupilumab

    Dupilumab

  • ATC code L04

    • Pharmaceutical drug classification

    Canakinumab L04AC09 Briakinumab L04AC10 Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab

    ATC code L04

    ATC_code_L04

  • Interleukin 12

    • Interleukin

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 12

    Interleukin 12

    Interleukin_12

  • Tocilizumab

    • Immunosuppressive drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Tocilizumab

    Tocilizumab

  • Interleukin 15 receptor, alpha subunit

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 15 receptor, alpha subunit

    Interleukin 15 receptor, alpha subunit

    Interleukin_15_receptor,_alpha_subunit

  • Theralizumab

    • Monoclonal antibody

    Adalimumab# Anifrolumab Atorolimumab Avelumab Avdoralimab Belimumab Bleselumab Brodalumab Camidanlumab tesirine Carlumab Cemiplimab Dupilumab Eldelumab Emapalumab

    Theralizumab

    Theralizumab

  • List of therapeutic monoclonal antibodies

    • rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis Brodalumab Siliq mab human IL-17 Y Plaque psoriasis Brolucizumab Beovu scFv humanized

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Interleukin 15

    • Cytokine with structural similarity to Interleukin-2

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 15

    Interleukin 15

    Interleukin_15

  • List of drugs: Br

    • Brixadi brobactam (INN) broclepride (INN) brocresine (INN) brocrinat (INN) Brodalumab (USAN, INN) brodimoprim (INN) Brodspec brofaromine (INN) Brofed brofezil

    List of drugs: Br

    List_of_drugs:_Br

  • Guselkumab

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Guselkumab

    Guselkumab

    Guselkumab

  • Interleukin

    • Group of cytokines

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin

    Interleukin

  • Secukinumab

    • Monoclonal antibody against IL-17

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Secukinumab

    Secukinumab

    Secukinumab

  • Ustekinumab

    • Biopharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Ustekinumab

    Ustekinumab

  • Interleukin 40

    • Mammalian cytokine

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 40

    Interleukin 40

    Interleukin_40

  • Interleukin 1 beta

    • Mammalian protein found in Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 1 beta

    Interleukin 1 beta

    Interleukin_1_beta

  • Daclizumab

    • Pharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Daclizumab

    Daclizumab

  • Interleukin 6

    • Cytokine protein

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 6

    Interleukin 6

    Interleukin_6

  • CD4

    • Marker on immune cells

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    CD4

    CD4

    CD4

  • Anakinra

    • Pharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Anakinra

    Anakinra

    Anakinra

  • Lebrikizumab

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Lebrikizumab

    Lebrikizumab

    Lebrikizumab

  • Institute for Clinical and Economic Review

    • alemtuzumab, and daclizumab for multiple sclerosis; and ixekizumab and brodalumab for psoriasis or psoriatic arthritis. ICER's governing boards include

    Institute for Clinical and Economic Review

    Institute_for_Clinical_and_Economic_Review

  • Interleukin 2

    • Mammalian protein found in humans

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 2

    Interleukin 2

    Interleukin_2

  • Canakinumab

    • Pharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Canakinumab

    Canakinumab

    Canakinumab

  • IL17RA

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL17RA

    IL17RA

    IL17RA

  • Interleukin 1 receptor, type I

    • Type of interleukin receptor

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 1 receptor, type I

    Interleukin 1 receptor, type I

    Interleukin_1_receptor,_type_I

  • Mepolizumab

    • Monoclonal antibody medication

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Mepolizumab

    Mepolizumab

  • Interleukin-17 receptor

    • Type of protein receptor

    marrow, thymus, and spleen tissue. Approved anti-IL-17(R) drugs include: Brodalumab (Siliq), an antibody targeting IL-17 receptor is approved for the treatment

    Interleukin-17 receptor

    Interleukin-17 receptor

    Interleukin-17_receptor

  • Interleukin-17A

    • Protein-coding gene in the species Homo sapiens

    (December 2013). "Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe

    Interleukin-17A

    Interleukin-17A

    Interleukin-17A

  • Anti-interleukin-6

    • Drugs to suppress IL-6 signalling

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Anti-interleukin-6

    Anti-interleukin-6

  • Interleukin 17

    • Group of proteins

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 17

    Interleukin 17

    Interleukin_17

  • Interleukin 8

    • Mammalian protein found in humans

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 8

    Interleukin 8

    Interleukin_8

  • Spartalizumab

    • Monoclonal antibody

    Adalimumab# Anifrolumab Atorolimumab Avelumab Avdoralimab Belimumab Bleselumab Brodalumab Camidanlumab tesirine Carlumab Cemiplimab Dupilumab Eldelumab Emapalumab

    Spartalizumab

    Spartalizumab

  • Monoclonal antibody therapy

    • Form of immunotherapy

    conjugate CD30 Hodgkin lymphoma Anaplastic large-cell lymphoma 125388 Link brodalumab Siliq Valeant 2/15/2017 subcutaneous chimeric IL17RA Plaque psoriasis

    Monoclonal antibody therapy

    Monoclonal antibody therapy

    Monoclonal_antibody_therapy

  • Interleukin 23

    • Heterodimeric cytokine acting as mediator of inflammation

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 23

    Interleukin 23

    Interleukin_23

  • ST2 cardiac biomarker

    • Member of the interleukin 1 receptor family

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    ST2 cardiac biomarker

    ST2_cardiac_biomarker

  • Basiliximab

    • Pharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Basiliximab

    Basiliximab

  • Interleukin 10

    • Anti-inflammatory cytokine

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 10

    Interleukin 10

    Interleukin_10

  • IL22RA2

    • Mammalian protein found in Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL22RA2

    IL22RA2

  • IL1RAP

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL1RAP

    IL1RAP

    IL1RAP

  • Interleukin 4

    • Mammalian protein found in Mus musculus

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 4

    Interleukin 4

    Interleukin_4

  • IL17RB

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL17RB

    IL17RB

    IL17RB

  • IL31RA

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL31RA

    IL31RA

    IL31RA

  • Interleukin 23 subunit alpha

    • Mammalian protein found in Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 23 subunit alpha

    Interleukin 23 subunit alpha

    Interleukin_23_subunit_alpha

  • Interleukin-1 family

    • Group of cytokine proteins

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-1 family

    Interleukin-1 family

    Interleukin-1_family

  • Interleukin 12 receptor, beta 2 subunit

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 12 receptor, beta 2 subunit

    Interleukin 12 receptor, beta 2 subunit

    Interleukin_12_receptor,_beta_2_subunit

  • Siltuximab

    • Pharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Siltuximab

    Siltuximab

  • Tralokinumab

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Tralokinumab

    Tralokinumab

    Tralokinumab

  • Benralizumab

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Benralizumab

    Benralizumab

  • Rilonacept

    • Medication

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Rilonacept

    Rilonacept

  • IL2RA

    • Mammalian protein found in Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL2RA

    IL2RA

    IL2RA

  • Interleukin 13

    • Protein and coding gene in humans

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 13

    Interleukin 13

    Interleukin_13

  • Tildrakizumab

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Tildrakizumab

    Tildrakizumab

  • Reslizumab

    • Pharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Reslizumab

    Reslizumab

  • Interleukin 31

    • Protein in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 31

    Interleukin 31

    Interleukin_31

  • Interleukin-1 receptor antagonist

    • Protein and coding gene in humans

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-1 receptor antagonist

    Interleukin-1 receptor antagonist

    Interleukin-1_receptor_antagonist

  • Interleukin-1 receptor family

    • Immunoglobulin superfamily

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-1 receptor family

    Interleukin-1_receptor_family

  • EBI3

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    EBI3

    EBI3

    EBI3

  • Interleukin 1-alpha

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 1-alpha

    Interleukin 1-alpha

    Interleukin_1-alpha

  • IL12A

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL12A

    IL12A

    IL12A

  • Interleukin 7

    • Growth factor secreted by stromal cells in the bone marrow and thymus

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 7

    Interleukin 7

    Interleukin_7

  • IL-2 receptor

    • Lymphocyte receptor specific for Interleukin-2

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL-2 receptor

    IL-2 receptor

    IL-2_receptor

  • Interleukin-23 receptor

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-23 receptor

    Interleukin-23 receptor

    Interleukin-23_receptor

  • Outline of immunology

    • Overview of and topical guide to immunology

    Nerelimomab Interleukin Anakinra Basiliximab Bimekizumab Briakinumab Brodalumab Canakinumab Daclizumab Netakimab Olokizumab Sarilumab Satralizumab Secukinumab

    Outline of immunology

    Outline_of_immunology

  • Gevokizumab

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Gevokizumab

    Gevokizumab

  • Interleukin 5

    • Type of cytokine

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 5

    Interleukin 5

    Interleukin_5

  • Sirukumab

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Sirukumab

    Sirukumab

  • Oprelvekin

    • Pharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Oprelvekin

    Oprelvekin

  • Interleukin-15 receptor

    • Protein complex

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-15 receptor

    Interleukin-15 receptor

    Interleukin-15_receptor

  • Interleukin-12 subunit beta

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-12 subunit beta

    Interleukin-12 subunit beta

    Interleukin-12_subunit_beta

  • Interleukin 34

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 34

    Interleukin 34

    Interleukin_34

  • Denileukin diftitox

    • Pharmaceutical drug

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Denileukin diftitox

    Denileukin_diftitox

  • Interleukin-6 receptor

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-6 receptor

    Interleukin-6 receptor

    Interleukin-6_receptor

  • Interleukin-10 receptor

    • Cell surface receptor for interleukin-10

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-10 receptor

    Interleukin-10_receptor

  • Interleukin 12 receptor, beta 1 subunit

    • Protein and coding gene in humans

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 12 receptor, beta 1 subunit

    Interleukin 12 receptor, beta 1 subunit

    Interleukin_12_receptor,_beta_1_subunit

  • Interleukin 21

    • Mammalian protein found in humans

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 21

    Interleukin 21

    Interleukin_21

  • Interferon lambda 3

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interferon lambda 3

    Interferon lambda 3

    Interferon_lambda_3

  • Interleukin 29

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 29

    Interleukin 29

    Interleukin_29

  • Interleukin-21 receptor

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-21 receptor

    Interleukin-21 receptor

    Interleukin-21_receptor

  • Sarilumab

    • Human monoclonal antibody medication

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Sarilumab

    Sarilumab

  • IL18BP

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    IL18BP

    IL18BP

    IL18BP

  • Interleukin 36 receptor antagonist

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 36 receptor antagonist

    Interleukin 36 receptor antagonist

    Interleukin_36_receptor_antagonist

  • Interleukin-4 receptor

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-4 receptor

    Interleukin-4 receptor

    Interleukin-4_receptor

  • Interleukin-12 receptor

    • Type I cytokine receptor

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-12 receptor

    Interleukin-12_receptor

  • Interleukin 22

    • Protein, encoded in humans by IL22 gene

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 22

    Interleukin 22

    Interleukin_22

  • Interleukin 11

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 11

    Interleukin 11

    Interleukin_11

  • Interleukin 3

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 3

    Interleukin 3

    Interleukin_3

  • Interleukin-9 receptor

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin-9 receptor

    Interleukin-9 receptor

    Interleukin-9_receptor

  • Anrukinzumab

    • Chemical compound

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Anrukinzumab

    Anrukinzumab

  • Interleukin 32

    • Protein found in humans

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 32

    Interleukin 32

    Interleukin_32

  • Interleukin 20

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 20

    Interleukin 20

    Interleukin_20

  • Pascolizumab

    • Monoclonal antibody

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Pascolizumab

    Pascolizumab

  • Common gamma chain

    • Protein-coding gene in humans

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Common gamma chain

    Common gamma chain

    Common_gamma_chain

  • Interleukin 1 receptor, type II

    • Protein-coding gene in the species Homo sapiens

    Agonists: Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:

    Interleukin 1 receptor, type II

    Interleukin 1 receptor, type II

    Interleukin_1_receptor,_type_II

AI & ChatGPT searchs for online references containing BRODALUMAB

BRODALUMAB

AI search references containing BRODALUMAB

BRODALUMAB

AI search queriess for Facebook and twitter posts, hashtags with BRODALUMAB

BRODALUMAB

Follow users with usernames @BRODALUMAB or posting hashtags containing #BRODALUMAB

BRODALUMAB

Online names & meanings

  • Gurpreet

    • Girl/Female

    Indian

    Gurpreet

    Love of Guru, Gurus Love

  • Ruchit | ருசித

    • Boy/Male

    Tamil

    Ruchit | ருசித

    Bright, Shining, Pleasant

  • Ihtesham

    • Boy/Male

    Muslim/Islamic

    Ihtesham

    Respectable honourable, present personality

  • Ketch

    • Surname or Lastname

    English

    Ketch

    English : variant of Kedge, a nickname from Middle English kedge ‘brisk’, ‘lively’, a dialect term confined to East Anglia (probably of Old Norse origin).

  • RUBE

    • Male

    English

    RUBE

    Pet form of English Reuben, RUBE means "behold, a son!" 

  • Ratannabha

    • Boy/Male

    Hindu

    Ratannabha

    Lord Vishnu

  • Kartar

    • Girl/Female

    Gujarati, Indian, Kannada, Punjabi, Sikh

    Kartar

    Creative Like God

  • Pralesh | ப்ரலேஷ 

    • Boy/Male

    Tamil

    Pralesh | ப்ரலேஷ 

    Finishes bad things

  • Aporajita

    • Boy/Male

    Indian

    Aporajita

    Flower

  • Ragheed

    • Boy/Male

    Indian

    Ragheed

    Comfort, Opulence, Pleasant

AI search & ChatGPT queriess for Facebook and twitter users, user names, hashtags with BRODALUMAB

BRODALUMAB

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing BRODALUMAB

BRODALUMAB

AI searchs for Acronyms & meanings containing BRODALUMAB

BRODALUMAB

AI searches, Indeed job searches and job offers containing BRODALUMAB

Other words and meanings similar to

BRODALUMAB

AI search in online dictionary sources & meanings containing BRODALUMAB

BRODALUMAB